BeStock  
Stocks › Biotechnology › AVLN

Avalyn Pharma AVLN

US equityMarket cap rank #3150Biotechnology
$25.53 +$0.10 (+0.39%)
Market closed · Oct 8, 7:00 am ET · Last extended-hours $25.53 0.00%
Open$25.30
Prev close$25.43
Day range$25.26 – $26.31
Volume202.9K
Market cap$1.13B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$0.00
Operating profit-$31.29M-43.7% YoY
Net profit-$28.94M-43.3% YoY
Diluted EPS-$0.65-35.2% YoY
Free cash flow-$26.35M-27.3% YoY
Operating cash flow-$26.08M

Revenue, last 4 quarters

$0.0Mar '25$0.0Jun '25$0.0Mar '26$0.0Jun '26

Net profit, last 4 quarters

$-17.5MMar '25$-20.2MJun '25$-26.9MMar '26$-28.9MJun '26

Diluted EPS by quarter

-0.42Mar '25-0.48Jun '25-0.64Mar '26-0.65Jun '26

Free cash flow by quarter

$-19.3MMar '25$-20.7MJun '25$-30.2MMar '26$-26.3MJun '26

Profitability & balance sheet

Return on equity-25.9%
Return on assets-24.3%
Return on invested capital-26.6%
Current ratio33.12
Liabilities / assets6.4%
Cash & investments$352.43M
Total debt$16.29M
Net cash (debt)$336.13M

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q2 2025 Q1
Net Income to Common Stockholders -$28.94M -$26.87M -$85.20M -$20.19M -$17.50M
Total Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expense $31.29M $27.91M $91.29M $21.78M $18.72M
Non-Operating Interest Expense $272,000.00 $98,000.00 – $0.00 $0.00
Selling and Admin Expenses $6.56M $5.02M $14.68M $3.90M $3.40M
-General & Admin Expense $6.56M $5.02M $14.68M $3.90M $3.40M
Diluted EPS -$0.65 -$0.64 -$2.04 -$0.48 -$0.42
Basic EPS -$0.65 -$0.64 -$2.04 -$0.48 -$0.42
Research & Development $24.73M $22.89M $76.61M $17.88M $15.32M
Operating Profit -$31.29M -$27.91M -$91.29M -$21.78M -$18.72M
Net Non-Operating Interest Income (Expense) $2.42M $1.03M $6.18M $1.63M $1.25M
Non-Operating Interest Income $2.70M $1.13M $6.18M $1.63M $1.25M
Other Income (Expense) -$69,000.00 $13,000.00 -$89,000.00 -$41,000.00 -$35,000.00
Pretax Profit -$28.94M -$26.87M -$85.20M -$20.19M -$17.50M
Net Profit -$28.94M -$26.87M -$85.20M -$20.19M -$17.50M
Profit from Continuing Operations -$28.94M -$26.87M -$85.20M -$20.19M -$17.50M
Net Income to Parent Company -$28.94M -$26.87M -$85.20M -$20.19M -$17.50M
Other Non-Operating Income (Expenses) -$69,000.00 $13,000.00 -$89,000.00 -$41,000.00 -$35,000.00

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2024 ANNUAL
-Accumulated Depreciation -$216,000.00 -$117,000.00 -$54,000.00 -$12,000.00
Investments and Advances $61.10M – $0.00 $7.49M
-Available for Sale Securities $61.10M – – $7.49M
Other Non-Current Assets $3.01M $3.00M $3.00M $2.55M
Total Liabilities $27.10M $399.91M $387.54M $299.04M
Total Current Liabilities $10.81M $11.79M $14.09M $8.74M
Payables $2.65M $3.15M $3.76M $2.28M
-Accounts Payable $2.65M $3.15M $3.76M $2.28M
Current Accrued Expenses $4.17M $6.29M $5.60M $3.72M
-Gross PPE $3.56M $2.79M $2.38M $106,000.00
Net PPE $3.35M $2.68M $2.32M $94,000.00
Total Assets $425.45M $135.66M $148.88M $124.52M
Total Current Assets $357.99M $129.99M $143.56M $114.39M
Cash and Cash Equivalents & Short-Term Investments $352.43M $123.13M $138.36M $110.63M
-Cash and Cash Equivalents $264.20M $92.31M $52.32M $23.96M
-Short Term Investments $88.23M $30.82M $86.04M $86.67M
Receivables $1.67M $253,000.00 $537,000.00 $591,000.00
-Accrued Interest Receivable $1.67M $253,000.00 $537,000.00 $591,000.00
Current Deferred Assets $221,000.00 $2.73M – –
Total Non-Current Assets $67.46M $5.68M $5.32M $10.13M
Total Non-Current Liabilities $16.29M $388.12M $373.45M $290.30M
Long Term Debt and Capital Lease Obligation $16.29M $15.90M $1.23M $0.00
-Long Term Debt $14.80M $14.81M – –
-Long Term Capital Lease Obligation $1.49M $1.09M $1.23M $0.00
Convertible preferred securities $0.00 $372.22M $372.22M $290.30M
Total Equity $398.35M -$264.25M -$238.66M -$174.52M
Stockholders' Equity $398.35M -$264.25M -$238.66M -$174.52M
Capital Stock $67,000.00 $24,000.00 $24,000.00 $5,000.00
-Common Stock $67,000.00 $24,000.00 $24,000.00 $5,000.00
Additional Paid-In Capital $719.54M $27.95M $26.55M $5.43M
Retained Earnings -$321.17M -$292.23M -$265.36M -$180.16M
Short-Term Debt and Capital Lease Obligation $816,000.00 $507,000.00 $444,000.00 –
-Current Capital Lease Obligation $816,000.00 $507,000.00 $444,000.00 $0.00
Gains/Losses Not Affecting Retained Earnings -$95,000.00 $12,000.00 $134,000.00 $202,000.00
Prepaid Assets $3.67M $3.88M $4.66M $3.17M

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q2 2025 Q1
Net Issuance Payments Of Debt $0.00 $15.00M – $0.00 $0.00
Net Cash Flow from Continuing Financing Activities $316.67M $14.86M $99.79M $89.88M $0.00
Financing Cash Flow $316.67M $14.86M $99.79M $89.88M $0.00
Net PPE Purchase and Sale -$269,000.00 -$318,000.00 -$344,000.00 $0.00 -$8,000.00
Net Cash Flow from Continuing Investing Activities -$118.71M $55.02M $10.06M -$36.69M $24.12M
Net cash flow from investing -$118.71M $55.02M $10.06M -$36.69M $24.12M
-Change in Other Current Liabilities -$122,000.00 -$70,000.00 -$7,000.00 $0.00 $0.00
-Change in Other Current Assets -$12,000.00 $0.00 -$450,000.00 $119,000.00 $120,000.00
-Change in Payables and Accrued Expense -$172,000.00 -$3.58M $4.25M -$1.01M -$1.62M
-Change in Prepaid Assets $316,000.00 -$508,000.00 -$1.19M -$279,000.00 -$265,000.00
Change in Working Capital $10,000.00 -$4.16M $2.61M -$1.17M -$1.77M
Proceeds from Stock Option Exercised $4,000.00 $25,000.00 $18,000.00 $0.00 $0.00
Net Other Financing Charges -$4.18M -$163,000.00 -$594,000.00 – –
Ending Cash Balance $264.20M $92.31M $52.32M $61.30M $28.80M
Net Investment Purchase and Sale -$118.44M $55.34M $10.40M -$36.69M $24.13M
Free Cash Flow -$26.35M -$30.21M -$81.83M -$20.70M -$19.28M
Beginning Cash Balance $92.31M $52.32M $23.96M $28.80M $23.96M
Net Change in Cash $171.89M $40.00M $28.36M $32.50M $4.84M
Other Non-Cash Items $129,000.00 $114,000.00 $146,000.00 – –
Depreciation & Depletion & Amortization $110,000.00 $63,000.00 $42,000.00 $9,000.00 $10,000.00
Operating Cash Flow -$26.08M -$29.89M -$81.48M -$20.70M -$19.28M
Net cash flow from continuing operations -$26.08M -$29.89M -$81.48M -$20.70M -$19.28M
Net Income from Continuing Operations -$28.94M -$26.87M -$85.20M -$20.19M -$17.50M
Net Preferred Stock Issuance – – $100.36M – –

Discussion

No comments yet — be the first to weigh in on AVLN.

Leave a comment

Scroll to Top